Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Lisa Anderson
Research Area(s) / Expertise: Job title: Heart Failure Consultant and Honorary Reader
Dr Lisa Anderson is a Heart Failure Consultant and Honorary Reader in the Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Research Institute at St George's Hospital in London, UK. Dr Anderson achieved her BSc and MB ChB from Liverpool in 1987 and 1990 respectively. She obtained her MD from Imperial College in 2001 before completing cardiology specialist registrar training… View more
Research Area(s) / Expertise: Job title: PhD, RD, FHFSA, FASPEN
Dr Salvatore Carbone, PhD, RDN, MS, FHFSA, FASPEN is an Associate Professor and Program Director of the Nutrition Program at the EVMS School of Health Professions, and an Associate Professor within the EVMS Division of Endocrine and Metabolic Disorders, Strelitz Diabetes Center, Department of Internal Medicine, at the Macon & Joan Brock Virginia Health Sciences at Old Dominion University… View more
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 1 year ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
Alexander Lyon
Research Area(s) / Expertise: Job title: Consultant Cardiologist
Dr Alexander Lyon is a leading London-based consultant cardiologist, specialising in the field of heart failure, cardiomyopathy, cardio-oncology and takotsubo syndrome. He is highly experienced, and is well-versed in all aspects of cardiology. Along with his private clinics at Royal Brompton Hospital and in central London, he is also senior lecturer for the National Heart and Lung Institute at… View more
Andrew Higgins
Research Area(s) / Expertise: Job title: Clinical Cardiologist & Associate Director of Cardiac ICU
Dr Andrew Higgins is a clinical cardiologist in sections of Critical Care Cardiology and Heart Failure and Transplant Cardiology at the Cleveland Clinic. He is the Associate Director of the Cardiac ICU and core faculty within the Heart Failure and Transplant Cardiology as well as the Critical Care Medicine fellowships. A graduate of the University of Colorado School of Medicine, Dr Higgins… View more
ESC 24 in Review with Dr Purvi Parwani
Added: 1 year ago
In this episode of Parallax, Dr Ankur Kalra reunites with Dr Purvi Parwani for a deep dive into the groundbreaking data unveiled at ESC Congress 2024.Dr Parwani, Director of the Women's Cardiovascular Disease Clinic and a leading expert in her field, serves as Associate Professor of Medicine and Director of the Echocardiography Laboratory for Advanced Cardiovascular Imaging at Loma Linda… View more

Intervention

Demographic
Teresa Taft Levitch is a strategic healthcare communicator, writer, and patient advocate whose work focuses on cancer rehabilitation, survivorship, and cardiovascular health. She has developed patient-centered content and campaigns for organisations including the CDC Foundation, AstraZeneca, Memorial Sloan Kettering Cancer Center, the American Heart Association, and the Cancer Survivorship &… View more
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
Added: 1 year ago Source:  ESC Congress
The European Society of Cardiology has revealed the late-breaking science sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30th August to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View… View more

Heart Failure

Electrophysiology & Arrhythmia
Beta-Blockers Show No Benefit Post-MI in Normal LVEF
Added: 7 months ago Source:  Radcliffe Cardiology
A large-scale meta-analysis of individual patient data has found that beta-blocker therapy does not reduce the risk of major adverse cardiovascular events in patients with a preserved left ventricular ejection fraction (LVEF) following a myocardial infarction (MI).¹ The findings, from the Beta-Blocker Trialists’ Collaboration Study Group, question the routine use of this drug class in this… View more

MI/ACS

Prevention & Chronic Conditions
Christophe Leclercq
Prof Christophe Leclercq is from the Centre Hospitalier Universitaire of Rennes (FR) and chief of the cardiology department. His main areas of interest include device therapy for arrhythmias and heart failure. He is a board member of the European Heart Rhythm Association, European Society of Cardiology and Heart Failure Association. View more